First American Scientific Corp. (FASC) Financials
Post# of 250675
Posted On: 11/17/2014 3:20:10 AM
First American Scientific Corp. (FASC) Financials Nov 14, 2014, 8:10 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for First American Scientific Corp.
Fiscal year is July-June. All values USD millions. 2007 2008 2009 2010 2011 5-year trend
Sales/Revenue 323,560 795,734 714,861 1.22M 86,106
Cost of Goods Sold (COGS) incl. D&A 399,708 611,304 426,936 946,504 899,896
COGS excluding D&A 232,739 426,827 250,987 758,562 727,252
Depreciation & Amortization Expense 166,969 184,477 175,949 187,942 172,644
Depreciation - - - 42,760 27,462
Amortization of Intangibles - - - 145,182 145,182
Gross Income (76,148) 184,430 287,925 271,562 (813,790)
2007 2008 2009 2010 2011 5-year trend
SG&A Expense 367,793 672,806 198,698 354,093 262,333
Research & Development 33,171 4,738 40,942 107,565 66,047
Other SG&A 334,622 668,068 157,756 246,528 196,286
Other Operating Expense 684,425 56,678 526,124 551,138 0
Unusual Expense 0 0 0 0 0
EBIT after Unusual Expense 0 0 0 0 0
Non Operating Income/Expense 41,399 118,764 201,674 (30,354) (45,127)
Non-Operating Interest Income 0 5 0 - -
Equity in Affiliates (Pretax) - (136,615) (249,338) - -
Interest Expense - - 0 - -
Gross Interest Expense - - 0 - -
Interest Capitalized 0 0 0 0 0
Pretax Income (1.09M) (562,900) (484,561) (664,023) (1.12M)
Income Tax 0 0 0 0 0
Income Tax - Current Domestic 0 0 0 - 0
Income Tax - Current Foreign 0 0 0 - 0
Income Tax - Deferred Domestic 0 0 0 - 0
Income Tax - Deferred Foreign 0 0 0 - 0
Income Tax Credits 0 0 0 - 0
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income (1.09M) (562,900) (484,561) (664,023) (1.12M)
Minority Interest Expense 0 0 0 0 0
Net Income (1.09M) (562,900) (484,561) (664,023) (1.12M)
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 - -
Net Income After Extraordinaries (1.09M) (562,900) (484,561) (664,023) (1.12M)
Preferred Dividends 0 0 0 0 0
Net Income Available to Common (1.09M) (562,900) (484,561) (664,023) (1.12M)
EPS (Basic) (0.01) () () () (0.01)
Basic Shares Outstanding 193.19M 197.48M 199.93M 199.95M 199.95M
EPS (Diluted) (0.01) () () () (0.01)
Diluted Shares Outstanding 193.19M 197.48M 199.93M 199.95M 199.95M
EBITDA (961,397) (360,577) (260,948) (445,727) (903,479)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for First American Scientific Corp.
Fiscal year is July-June. All values USD millions. 2007 2008 2009 2010 2011 5-year trend
Sales/Revenue 323,560 795,734 714,861 1.22M 86,106
Cost of Goods Sold (COGS) incl. D&A 399,708 611,304 426,936 946,504 899,896
COGS excluding D&A 232,739 426,827 250,987 758,562 727,252
Depreciation & Amortization Expense 166,969 184,477 175,949 187,942 172,644
Depreciation - - - 42,760 27,462
Amortization of Intangibles - - - 145,182 145,182
Gross Income (76,148) 184,430 287,925 271,562 (813,790)
2007 2008 2009 2010 2011 5-year trend
SG&A Expense 367,793 672,806 198,698 354,093 262,333
Research & Development 33,171 4,738 40,942 107,565 66,047
Other SG&A 334,622 668,068 157,756 246,528 196,286
Other Operating Expense 684,425 56,678 526,124 551,138 0
Unusual Expense 0 0 0 0 0
EBIT after Unusual Expense 0 0 0 0 0
Non Operating Income/Expense 41,399 118,764 201,674 (30,354) (45,127)
Non-Operating Interest Income 0 5 0 - -
Equity in Affiliates (Pretax) - (136,615) (249,338) - -
Interest Expense - - 0 - -
Gross Interest Expense - - 0 - -
Interest Capitalized 0 0 0 0 0
Pretax Income (1.09M) (562,900) (484,561) (664,023) (1.12M)
Income Tax 0 0 0 0 0
Income Tax - Current Domestic 0 0 0 - 0
Income Tax - Current Foreign 0 0 0 - 0
Income Tax - Deferred Domestic 0 0 0 - 0
Income Tax - Deferred Foreign 0 0 0 - 0
Income Tax Credits 0 0 0 - 0
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income (1.09M) (562,900) (484,561) (664,023) (1.12M)
Minority Interest Expense 0 0 0 0 0
Net Income (1.09M) (562,900) (484,561) (664,023) (1.12M)
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 - -
Net Income After Extraordinaries (1.09M) (562,900) (484,561) (664,023) (1.12M)
Preferred Dividends 0 0 0 0 0
Net Income Available to Common (1.09M) (562,900) (484,561) (664,023) (1.12M)
EPS (Basic) (0.01) () () () (0.01)
Basic Shares Outstanding 193.19M 197.48M 199.93M 199.95M 199.95M
EPS (Diluted) (0.01) () () () (0.01)
Diluted Shares Outstanding 193.19M 197.48M 199.93M 199.95M 199.95M
EBITDA (961,397) (360,577) (260,948) (445,727) (903,479)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
(0)
(0)